Insulet Shares Drop After Second 2026 Pod Correction; Quality Concerns Weigh on Stock
Insulet shares slid sharply after the company announced a second voluntary Medical Device Correction in 2026, affecting specific lots of its Omnipod 5, Omnipod DASH and Omnipod Eros pods because of a manufacturing defect that can lead to insulin under-delivery. The announcement, paired with prior corrective actions and analyst target adjustments, i…